MHRA Approves Gene-Editing Treatment for Children With Blood Disorders
The UK regulator approved the gene-editing treatment for children aged five and over with serious inherited blood disorders.
The UK regulator approved the gene-editing treatment for children aged five and over with serious inherited blood disorders.